Nicotine Sainsbury’s Healthcare (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Nicotine Sainsbury’s Healthcare, is a nicotinic receptor agonist presented as an oral formulation for smoking cessation use. It helps adult smokers manage withdrawal symptoms and supports the process of quitting tobacco. GNH USA supplies Nicotine Sainsbury’s Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine Resinate is used in smoking cessation by targeting nicotinic acetylcholine receptors.

Smoking cessation: assists adult smokers in reducing nicotine cravings and withdrawal symptoms. Tobacco dependence: supports patients who wish to quit regular use of cigarettes or other tobacco products. Relapse prevention: helps maintain abstinence by lowering the likelihood of returning to smoking after initial cessation.

Common Side Effects: - Nausea - Headache - Insomnia - Dry mouth - Dizziness - Gastrointestinal discomfort

Serious or Rare Side Effects: - Cardiovascular events (e.g., hypertension, arrhythmia) - Severe allergic reaction (anaphylaxis) - Hypertensive crisis - Seizures - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Respiratory distress

Before initiating therapy, consider the following precautions:

Assess cardiovascular status: evaluate patient history for hypertension or heart disease. Monitor for signs of nicotine toxicity: watch for vomiting, confusion, or rapid heart rate. Avoid use in uncontrolled hypertension: contraindicated in patients with severe high blood pressure. Consider pregnancy status: safety has not been established; discuss risks with a healthcare professional. Avoid concurrent nicotine replacement products: may increase risk of overdose. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Nicotine Resinate may interact with several drug classes. Review the following interactions before prescribing.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other nicotine replacement therapies: potential for nicotine overdose. - Certain antihypertensives (e.g., beta‑blockers): may blunt therapeutic effect.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors: may increase nicotine plasma levels. - Alcohol: can enhance cardiovascular effects of nicotine. - SSRIs and other antidepressants: monitor for increased side‑effects such as insomnia or agitation.